ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75ECOG-ACRIN logo[19516]275×75
  • Home
  • Archive
  • Contact
✕

News from the ECOG-ACRIN Cancer Research Group
June 29, 2026
June 29, 2026
Categories
  • From the Co-Chairs

From the Co-Chairs, June 2026

An update on federal funding and policy developments shaping the future of cancer research
Do you like it?
0 Read more
June 29, 2026
June 29, 2026
Categories
  • Active Clinical Trials

Coming Soon: EAA242 for Patients With Early Relapse of Multiple Myeloma

This trial is testing an immune-based treatment combination (teclistamab and pomalidomide) for patients with multiple myeloma that has come back early
Do you like it?
0 Read more
June 29, 2026
Patient on PET-CT scan table
June 29, 2026
Categories
  • Active Clinical Trials

Trial Spotlight: Neha Vapiwala Provides an Update on the EA8191/INDICATE Study for Patients With Prostate Cancer Showing Signs of Recurrence After Surgery

This study is using PET imaging to guide treatment for prostate cancer recurrence
Do you like it?
0 Read more
June 29, 2026
Research definition
June 29, 2026
Categories
  • Trial Results

Trial Results: ECOG-ACRIN Research at ASCO and SNMMI 2026

The latest findings in brain tumors, breast cancer, kidney cancer, lung cancer, Merkel cell carcinoma, and precision oncology
Do you like it?
0 Read more
June 29, 2026
News in Brief image
June 29, 2026
Categories
  • News in Brief

News in Brief, June 2026

Timely information about research presented at medical meetings, recognition of research leaders, and more
Do you like it?
0 Read more

A blog to share information with our members, staff, and the cancer research community

✕

Categories

  • From the Co-Chairs
  • Active Clinical Trials
  • Institution Spotlights
  • Special Topics
  • People
  • News in Brief
  • Trial Results
  • Active ECOG-ACRIN Trials
  • ECOG-ACRIN.org
STAY UP TO DATE

Opt in to ensure we deliver this monthly blog directly to your inbox. We will never share your email.

Select list(s) to subscribe to


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc